All articles by
Alcresta Therapeutics gets FDA nod for RELiZORB digestive enzyme cartridge
The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted 510(k) clearance…
BlueWind Medical introduces Revi iTNM device to patients in Louisiana, US
US-based neuro-stimulation device maker BlueWind Medical has introduced its Revi implantable Tibial NeuroModulation (iTNM) solution in Shreveport, Louisiana, US. Revi…
Body Vision Medical Expands Distribution Footprint in Central and South America
Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today its exclusive distribution agreements with DeLeC CientÃfica Uruguaya S.A.…
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker
TRiCares SAS, a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to…
Perfuze gets FDA nod for neurovascular aspiration and access catheters
Ireland-based Perfuze has received the US Food and Drug Administration (FDA) approval for the Millipede 070 Aspiration Catheter and the…
Pulse Biosciences reports FIH trial of CellFX nsPFA cardiac catheter
US-based Pulse Biosciences has reported the completion of the first five procedures in its first-in-human (FIH) feasibility study with its…
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k)…
Boomerang Medical’s IBD Neuromodulation Study Successfully Completes Enrollment Milestone
Boomerang Medical, Inc., a women-led bioelectronic medicine company focused on autoimmune diseases, proudly announced the completion of Stage 2 of…
Owkin and MSD collaborate to develop AI-powered cancer diagnostics
French-American biotechnology firm Owkin has signed a collaboration agreement with MSD to develop and commercialise artificial intelligence (AI)-driven cancer diagnostics.…
ShiraTronics implants its Chronic Migraine System in six patients
US-based medical device company ShiraTronics has implanted its ShiraTronics Chronic Migraine System in the world’s first six patients. ShiraTronics said…